Identifying Tyrosine Kinase Inhibitor Non-adherence in Chronic Myeloid Leukemia: a sub-analysis of the TAKE-IT pilot study
Identifying non-adherence in chronic myeloid leukemia (CML) remains a challenge. Tyrosine kinase inhibitor adherence was measured by electronic monitoring and BAASIS © self-report in 55 CML patients over 4 months. The BAASIS© had 67% sensitivity and 71% specificity for diagnosing non-adherence. The BAASIS© and the risk factors for non-adherence found in this study provide a basis for identifying non-adherent CML patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Avi Leader, Anat Gafter – Gvili, Noam Benyamini, Juliet Dreyer, Bronya Calvarysky, Alina Amitai, Osnat Yarchovsky-Dolberg, Giora Sharf, Eric Tousset, Opher Caspi, Martin Ellis, Itai Levi, Pia Raanani, Sabina De Geest Tags: Original Study Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia | Lymphoma | Myeloma | Study